In the wake of recent U.S. elections, global markets have experienced significant shifts, with major indices like the small-cap Russell 2000 Index showing notable gains as investors anticipate potential policy changes that could spur economic growth. Amidst this dynamic landscape, identifying high-growth tech stocks becomes crucial for investors seeking to capitalize on emerging opportunities; factors such as innovation potential and adaptability to regulatory changes are key considerations in evaluating these stocks.
|
Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
|---|---|---|---|
|
Material Group |
20.45% |
24.01% |
★★★★★★ |
|
Yggdrazil Group |
24.66% |
85.53% |
★★★★★★ |
|
eWeLLLtd |
26.52% |
27.53% |
★★★★★★ |
|
Medley |
24.98% |
30.36% |
★★★★★★ |
|
Seojin SystemLtd |
33.39% |
49.13% |
★★★★★★ |
|
Sarepta Therapeutics |
23.89% |
42.65% |
★★★★★★ |
|
Mental Health TechnologiesLtd |
27.88% |
79.61% |
★★★★★★ |
|
Alnylam Pharmaceuticals |
22.45% |
70.66% |
★★★★★★ |
|
Travere Therapeutics |
31.19% |
72.58% |
★★★★★★ |
|
UTI |
114.97% |
134.60% |
★★★★★★ |
Click here to see the full list of 1284 stocks from our High Growth Tech and AI Stocks screener.
Let’s review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: ALSO Holding AG is a technology services provider for the ICT industry, operating in Switzerland, Germany, the Netherlands, Poland, and internationally with a market capitalization of CHF2.90 billion.
Operations: The company generates revenue primarily from its operations in Central Europe (€4.62 billion) and Northern/Eastern Europe (€5.24 billion). The business model focuses on providing technology services within the ICT industry across multiple regions, with a notable presence in both Central and Northern/Eastern Europe.
ALSO Holding AG, navigating through a challenging tech landscape, has demonstrated resilience with a projected revenue growth of 13% annually, outpacing the Swiss market’s 4.1%. Despite a recent downturn in earnings by 20.4%, contrasting with the industry’s average of -12.4%, the company is poised for significant recovery with expected earnings growth at an impressive rate of 26.8% per year. This rebound is underscored by their robust R&D investments which have strategically positioned them for future innovations and market competitiveness. At the Baader Investment Conference, ALSO highlighted these strategies, reinforcing their commitment to evolving in high-tech arenas despite current volatilities.
-
Unlock comprehensive insights into our analysis of ALSO Holding stock in this health report.
-
Understand ALSO Holding’s track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
